Epstein Secrets

s, the plea agreement killed an F.B.I. investigation and granted immunity to any "co-conspirators." As detailed last fall in a blockbuster series by Julie K. Brown of The Miami Herald, Mr. Acosta and his office worked unusually closely with Mr. Epstein's legal team on the deal. Both sides also labored to keep

in stories, even as he receded from headlines at most outlets. Aminda Marques Gonzalez, the Herald's executive editor, said in a CNN interview that Brown's investigation of Epstein last year stemmed from reporting on women's prisons and human trafficking. "Jeffrey Epstein's name kept coming up again

t it contemplates his criminal prosecution." Kordel, 397 U.S. at 11-12 (emphasis added). In Kordel, a corporate executive was convicted of violating the Food, Drug, and Cosmetic Act partly on the basis of earlier answers to interrogatories served on his company by the Food and Drug Administration (FDA) in a ci

s, the plea agreement killed an F.B.I. investigation and granted immunity to any "co-conspirators." As detailed last fall in a blockbuster series by Julie K. Brown of The Miami Herald, Mr. Acosta and his office worked unusually closely with Mr. Epstein's legal team on the deal. Both sides also labored to keep

in stories, even as he receded from headlines at most outlets. Aminda Marques Gonzalez, the Herald's executive editor, said in a CNN interview that Brown's investigation of Epstein last year stemmed from reporting on women's prisons and human trafficking. "Jeffrey Epstein's name kept coming up again

it contemplates his criminal prosecution." Kordel, 397 U.S. at 11-12 (emphasis added). In Kordel, a corporate executive was convicted of violating the Food, Drug, and Cosmetic Act partly on the basis of earlier answers to interrogatories served on his company by the Food and Drug Administration (FDA) in a ci

B. Zwany, Arthur P. Hui, Sarah J. Lum, Gary R. Brown, Assistant United States Atter- •7he Honorable Mi

ith their access to the drug. The Supreme Court rejected the patients' claims. The Court agreed with FDA that the new drug approval provisions of the Food, Drug, and Cosmetic Act spe- cifically applied to the situation presented. (171 In one respect, however, the fact that Dr. Burzynski and his patients wer